Biorelevant Dissolution Models for a Weak Base To Facilitate Formulation Development and Overcome Reduced Bioavailability Caused by Hypochlordyria or Achlorhydria
Dawen Kou(Sunesis (United States)), Peter Yehl(Sunesis (United States)), Leslie W. Chinn(University of California, San Francisco), Sudharsan Dwaraknath(University of Illinois Urbana-Champaign), Chen Mao(Sunesis (United States)), Larry Wigman(Sunesis (United States)), Myeong-Hui Kim(Pfizer (South Korea)), Helen Winter(Hackensack University Medical Center), Matthew R. Durk(University of Illinois Urbana-Champaign), Yannick Fischer(FHNW University of Applied Sciences and Arts Northwestern Switzerland), Daniel Nguyen(Sunesis (United States)), Hiuwing Yiu(Sunesis (United States)), Tania Ng(Sunesis (United States)), Preeti Patel(Indo Soviet Friendship College of Pharmacy)
Cited by 14
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
|The Lancet Oncology|2023|195
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
|European Journal of Medicinal Chemistry|2021|72